Status:
UNKNOWN
Anti-Mullerian Hormone as Predictor of Ovarian Responce to Clomiphene Citrate in PCOS
Lead Sponsor:
Ain Shams University
Conditions:
Polycystic Ovary Syndrome
Eligibility:
FEMALE
20-35 years
Phase:
NA
Brief Summary
Polycystic ovary syndrome (PCOS) is found in 5% to 6% of women of reproductive age. It affects women's reproductive capability; thus patients have risks of infertility, miscarriage, and complicated pr...
Eligibility Criteria
Inclusion
- Women diagnosed with PCOS
- Women 20-35 years old.
- BMI ≤30 kg/m without previous ovulation induction.
- Partners with normal semen parameters Parameter World Health Organization (WHO) 2010 Volume1.5 ml Concentration 15 million/ml Progressive motility 32% Normal forms 4%
Exclusion
- Women with evidence of hyper-or hypothyroidism, hyperprolactinemia, Cushing's syndrome, congenital adrenal hyperplasia or androgen-secreting tumors.
- Women with factors of infertility other than PCOS
- Women with incomplete data.
Key Trial Info
Start Date :
July 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2018
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03316469
Start Date
July 1 2018
End Date
December 1 2018
Last Update
June 27 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.